James J. Burns & Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

James J. Burns & Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,084	Closed	-$339K	–	163
2025 Q2	$339K	Buy	4,084 +1,027	+34%	+$81.9K	0.06%	112
2025 Q1	$248K	Buy	3,057 +4	+0.1%	+$358	0.04%	130
2024 Q4	$275K	Buy	3,053 +29	+1%	+$2.81K	0.05%	127
2024 Q3	$299K	Buy	3,024 +49	+2%	+$4.81K	0.05%	110
2024 Q2	$275K	Buy	+2,975	New	+$267K	0.05%	107
2024 Q1	–	Sell	-2,993	Closed	-$267K	–	124
2023 Q4	$267K	Sell	2,993 -69	-2%	-$5.12K	0.06%	101
2023 Q3	$224K	Buy	3,062 +146	+5%	+$11.7K	0.06%	96
2023 Q2	$242K	Sell	2,916 -178	-6%	-$14.9K	0.06%	100
2023 Q1	$236K	Buy	+3,094	New	+$257K	0.06%	105

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

James J. Burns & Company's XBI Position: Q3 2025 in Review

James J. Burns & Company sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 4,084 shares — an estimated $339K sold.

James J. Burns & Company first reported a position in XBI in Q1 2023 and held it in 9 quarters. The position peaked at $339K in Q2 2025. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

James J. Burns & Company reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
James J. Burns & Company sold 4,084 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $339K.
James J. Burns & Company first reported a position in State Street SPDR S&P Biotech ETF in Q1 2023 and held it in 9 quarters.
James J. Burns & Company's State Street SPDR S&P Biotech ETF position peaked at $339K in Q2 2025.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on James J. Burns & Company's 13F filing for Q3 2025, filed 20 Oct 2025.